Symbio develops and manufactures a diverse portfolio of Active Pharmaceutical Ingredients (APIs) and pharmaceutical enzymes, spanning multiple therapeutic areas and complex chemistries. Each product is built on our research-led development engine, emphasizing process optimization, green chemistry, and scalable innovation across our facilities in India.
Our portfolio continues to evolve through strategic collaborations and CDMO partnerships, where we co-develop advanced intermediates, APIs, and enzymes for both regulated and emerging markets. To explore collaboration opportunities or request our detailed product list, please contact [email protected]